NEW BRUNSWICK – Rutgers University is “strongly recommending” its students to get vaccinated against meningitis type B strain after two cases were confirmed last month on campus.
The recommendation is for all students, even if they live off-campus, and for graduate learners who live in undergraduate residence halls.
The university made the statement on March 12 as the state Department of Health declared “an outbreak of meningitis B at Rutgers-New Brunswick,” because two students were diagnosed with the illness.
“Students’ health, safety and well-being are our highest priority,” the university said in the statement. “To protect the student population, we are strongly recommending that all Rutgers-New Brunswick undergraduate students and graduate students who live in undergraduate residence halls become vaccinated against meningitis type B. Immunization is the best protection against this disease.”
The university noted that while students would have received vaccination against types A, C, W and Y, it does not protect against type B, which is the strain involved in the outbreak.
Students can get the vaccination at the student health centers, on-campus clinics or at their health care provider or select pharmacies.
No new cases have been reported since February, the university said.
Though rare, the illness can be dangerous. Symptoms can include high fever, severe headache, stiff neck, nausea, vomiting and rash among others, similar to the flu.
For anyone concerned, health experts recommend visiting a medical professional. More information is available at health.rutgers.edu/meningitis.
The university is continuing all operations and functions as usual.